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ABSTRACT  
 
Fat-associated lymphoid clusters (FALCs) are a recently discovered type of lymphoid 
tissue associated with visceral fat. Here we show that distribution of FALCs was 
heterogeneous with the pericardium containing large numbers of these clusters. FALCs 
contributed to the retention of B-1 B cells in the peritoneal cavity through high expression 
of the chemokine CXCL13 and supported B cell proliferation and germinal center 
differentiation during peritoneal immune challenges. FALC formation was induced by 
inflammation, which triggered recruitment of myeloid cells that express tumor necrosis 
factor (TNF) necessary for TNF receptor-signaling in stromal cells. CD1d-restricted Natural 
killer T (NKT) cells were likewise required for inducible formation of FALCs. Thus, FALCs 
support and coordinate innate B and T cell activation during serosal immune responses.  
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INTRODUCTION 
 
The peritoneal and pleural cavities support rapid immune responses when the integrity of 
the intestine or the lungs is compromised or lost. They contain innate-like B cell 
populations producing natural antibodies vital for the early control of infections, protecting 
against auto-immunity and contributing to adaptive immunity1-7. These B-1 cells recirculate 
between the peritoneal space and the omentum8, a sheet of intra-abdominal adipose 
tissue containing lymphoid structures called “milky spots”9-12. Upon peritoneal inflammation 
the number and size of milky spots increases and the recruitment of lymphocytes and 
macrophages phagocytosing particles and pathogens is substantially augmented9, 11, 12. 
The omentum also acts as a secondary lymphoid structure that promotes immunity to 
peritoneal antigens10, 12. 
 The existence of B cell-rich clusters in adipose tissue (AT) has recently been 
extended to the rest of the visceral fat in the peritoneal and pleural cavity13, 14. Moro and 
collaborators named them Fat Associated Lymphoid Clusters (FALCs)14. Their presence 
was associated with the presence of Group 2 innate lymphoid cells  (ILC2)14-17 in visceral 
AT, yet no direct evidence has shown that ILC2s induce formation of FALCs14. The exact 
composition of these clusters, their relative distribution in AT as well as their function and 
the mechanisms regulating their formation remain unknown.  
 Here we show that the distribution of lymphoid structures in AT was very 
heterogeneous, with the omentum, the pericardium and mediastinum being the tissues 
that contained the largest number of FALCs. We report that the development of FALCs 
was regulated by unique cellular and molecular mechanisms that, in contrast to other 
secondary lymphoid tissues, did not involve lymphoid tissue inducer (LTi) cells, ILC3s or 
the lymphotoxin beta receptor (LTβR) pathway18-20. Their postnatal formation was partly 
dependent on tumor necrosis factor receptor (TNFR) signaling and the presence of the 
commensal flora. FALC stromal cells expressed high amounts of the chemokine CXCL13 
that was crucial for the recruitment and retention of B cells in the clusters. Inflammation-
induced formation of FALCs required TNF expression by myeloid cells and TNFR-
signaling in stromal cells. Peritoneal immunization with T-independent and T-dependent 
antigens induced B cell differentiation into plasma cells and germinal center (GC)-like B 
cells in FALCs indicating an important function of these clusters during immune responses. 
Finally, we show that CD1d-restricted natural killer T (NKT) cells, a subset of T cells 
enriched in ATs, and interleukin 13 (IL-13) played a key role in inflammation-induced 
FALC formation.  
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RESULTS 
 
Visualization and characterization of FALCs 
 
Whole-mount immunofluorescence staining of the main visceral AT allowed, with a 
fluorescence stereomicroscope, the visualization (Fig. 1a) and enumeration of the CD45+ 
cell clusters present in the omental, gonadal, mesenteric, mediastinal and pericardial fat. 
In the peritoneal cavity, the omentum was the fat depot with the highest density of 
lymphoid clusters (8000 clusters/g) with a mean of 80 milky spots per omentum. The 
mesenteric fat depot contained a median of 120 clusters/g with a mean of 16 clusters per 
mesentery while gonadal AT had 8 clusters/g with a mean of 1–2 clusters per depot  (Fig. 
1b). In the pleural cavity, the pericardium had the highest density of lymphoid clusters 
(5400 clusters/g) with a mean of 40 clusters per tissue. The mediastinum with a density of 
2100 clusters/g and a mean of 9 clusters per mediastinum, accounted for the rest of the 
FALCs in the pleural cavity (Fig. 1b). This analysis revealed the high heterogeneity in the 
lymphoid cluster content of ATs.  
 The cellular composition of the clusters was characterized using whole mount 
immunofluorescence staining of mouse mesenteries with anti CD4, CD45, IgM and CD11b 
Abs followed by confocal microscopy analysis. In resting conditions FALCs were mostly 
composed of IgM+ B cells, with low numbers of CD4+ T cells and CD11b+ myeloid cells 
(Fig. 1c and Supplementary Fig.1). Clusters of different sizes and degrees of B-T cell 
segregation could be observed in individual mice (Supplementary Fig.1). A fraction of B 
cells expressed CD11b and abundant surface IgM, indicating that these were likely B-1 B 
cells. We did not detect any differences in the hematopoietic composition of FALCs from 
the mesenteries, mediastinum or pericardium that resembled the milky spots of the 
omentum (data not shown). FALCs appeared to be highly vascularized, as shown by the 
presence of CD31+ blood vessels. However, no clear connection with Lyve-1+ lymphatic 
vasculature could be detected. Only scattered Lyve-1+ macrophages were seen in close 
proximity of FALCs (Fig. 1d). 
The mesenteric ATs, where FALCs were easier to identify and enumerate, were 
used in the rest of the study. FALC formation was initiated after birth, with the first clusters 
identified in the mesenteries of two- to three-week old animals and their number increasing 
to reach a plateau at around 18 weeks of age (Fig. 1e). These results showed that FALCs 
are present in different visceral ATs in variable numbers and contained mainly B cells, with 
low numbers of T and myeloid cells.  
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CXCL13 is highly expressed by stromal cells in FALCs 
 
To understand how B and T cells were recruited to FALCs, we assessed the expression of 
genes encoding the homeostatic chemokines Cxcl13, Ccl21 and Ccl19 and the cytokine 
Il7 by qPCR analysis in isolated clusters. Cxcl13 expression was particularly high in 
FALCs as compared to the associated AT (>100 fold) or lymph nodes (LN) (10 fold). In 
contrast, Ccl21, Ccl19 and Il7 transcripts were not enriched in FALCs compared to the 
other tissues analyzed (Fig. 2a). In agreement with these findings, the number and 
composition of FALCs in CCL21- and CCL19-deficient mice (plt/plt) and Ccr7–/– mice 
presented no differences with their wild-type counterparts (Fig. 2b). Tnf and Ltb transcripts 
were both highly expressed in FALCs, which might reflect the high content of B cells in 
these clusters.  
 Immuno-fluorescence staining revealed the presence of CD45–CXCL13+ stromal 
cells with an elongated morphology (Fig. 2d) that resembled follicular dendritic cells 
(FDCs). LTβR and/or TNFR signaling is involved in inducing Cxcl13 expression in spleen 
and LN FDCs21-23. However, CXCL13+ cells were present in FALCs of Ltbr–/–, TNFR1-
TNFR2 double-deficient (Tnfrsf1a–/–Tnfrsf1b–/–) and Rag2–/– mice, demonstrating that 
CXCL13  expression by FALC stromal cells was independent of signals induced by these 
receptors and the presence of lymphocytes (Fig. 2d)24, 25. 
 To test whether CXCL13 expression was required for the recruitment of B cells in 
FALCs, we analyzed the Cxcr5–/– mice, deficient for the CXCL13 receptor. A normal 
number of FALCs formed in the mesenteries of these mice, but the number of B cells 
present in the clusters was markedly reduced. Thus, CXCL13 was not important for FALC 
formation but was essential for the recruitment of B cells (Fig. 2b,c). These data are 
consistent with previous reports showing that mesenteric and omentum tissues are 
important sources of CXCL13 required for the retention of peritoneal B cells. Overall, we 
demonstrate that the presence of CXCL13 in the mesenteries is due to its specific 
expression by FALC stromal cells and not the surrounding VAT. 
 
FALCs support B cell proliferation and differentiation  
 
B-1 cells are important for immune responses against T-independent (TI) antigens2, 5, 26-31. 
To assess B cell responses in FALCs, we used the TI antigen 4-hydroxy-3-
nitrophenylacetyl (NP)-Ficoll to immunize QM/QM (IghNP/NPIgk–/–) mice, which have a 
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quasi-monoclonal primary B cell repertoire specific for NP32. Flow-cytometric analysis of 
the proliferation marker Ki67 revealed that both B-1 and B-2 cells were proliferating in the 
mesenteries 24 h post intraperitoneal immunization. The percentage of Ki67+ proliferating 
B-1 cells was three times higher in the mesenteries than in the peritoneal cavity lavage or 
the spleen, reaching 70% for CD5+ B-1a, 50% for CD5– B-1b and 40% for CD5+CD11b– B-
1c cells. Up to 40% of B2 cells also proliferated in response to NP-Ficoll (Supplementary 
Fig. 2a,b). Whole mount staining of the mesenteries 24 h after immunization showed a 
marked enlargement of FALCs and an increased frequency of IgM+ cells (Supplementary 
Fig. 2c).  
To confirm that FALC B cells secreted IgM, we assessed the number of antibody-
forming cells (AFCs) in QM × C57BL/6 (B6) (IghNP/wtIgk–/wt)) mice33, which contain 5% of 
NP-specific B cells, four days after NP-Ficoll IP immunization. ELISPOT analysis 
confirmed an expansion of NP-specific B cells expressing IgM in the immunized animals 
(Fig. 3a top) as well as a significant increase in the number of IgG+ AFC in FALCs and 
spleen (Fig. 3a bottom and Fig. 3b). Further evidence of Ig switching in FALCs was 
obtained by NP-Ficoll immunization of Cγ1-CrexQMmTmG mice (IghNP/Cγ1Cre Igk–/– 
mTmG+/wt). These mice carry one copy of the Cre recombinase gene in the constant 
region of the Cγ1 Igh gene, one copy of the NP-specific Igh from QM mice and the 
membrane Tomato membrane Green (mTmG) reporter. NP immunization induced B cell 
activation and Ig class switching with the concomitant expression of Cre recombinase that 
resulted in the membrane reporter switch from IgM (red) to IgG (green). Whole mount 
immuno-fluorescence analysis revealed that NP-Ficoll immunisation induced the 
appearance of clusters of class-switched green B cells in the mesenteries (Fig. 3b). The 
early and preferential proliferation of B-1 cells in FALCs, and the presence of IgM- and 
IgG-producing cells demonstrated that these clusters contribute to peritoneal cavity B-1 
cells immune responses to type II antigens.  
The role of FALCs in T-dependent immune responses was tested by adoptive 
transfer of peritoneal lavage cells from QM/QM EYFP+/- mice into C57BL/6J recipients that 
were immunized subsequently with alum precipitated–NP-ovalbumin (OVA) by 
intraperitoneal injection. Flow cytometric analysis of cells isolated eight days after 
immunization showed a statistically significant increase in the frequency and number of 
Ag-specific B cells and CD38–GL7+ GC-like B cells in FALCs, spleen and mesenteric 
(m)LNs (Fig. 3c,d and data not shown). An endogenous immune response was elicited by 
intraperitoneal immunization of C57BL/6J mice with alum precipitated-phycoerythrin (PE). 
In agreement with the results above, flow-cytometric analysis of FALCs, spleen and mLN 
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showed a 20-fold increase in the proportion and number of PE-specific B cells and GC-like 
B cells (Fig. 3e,f and data not shown). Taken together, these results indicate that FALCs 
function as lymphoid tissues by supporting early activation of B cells during inflammation 
and differentiation towards plasma cells and germinal center cells during adaptive immune 
responses in the peritoneal cavity.  
 
Cells and signals required for FALC development 
 
The development of LNs and Peyer’s patches is dependent on the activity of LTi cells and 
engagement of the LTβR18-20. To determine whether the formation of FALCs followed the 
same cues, we assessed their presence in the Ltbr–/–, Lta–/– and Rorc–/– mouse strains in 
which LN development is fully impaired34-36. The number and composition of FALCs in 
these strains was identical to wild-type mice, indicating that the development of FALCs 
was independent of LTi or ILC3 cells and LTβR engagement (Fig. 4a,b). To determine 
whether any other lymphoid cell type was involved in FALC formation, we analyzed Rag2–
/– mice, lacking lymphocytes, and Rag2–/–Il2rg–/– mice that are deficient in lymphocytes and 
ILCs. FALCs were present in normal numbers in Rag2–/– mice, however they were absent 
in Rag2–/–Il2rg–/– mice, revealing a potential requirement for ILCs and/or NK cells to initiate 
cluster formation. Il15–/– mice have similar FALC numbers to their wild-type counterparts, 
ruling out a role for NK cells in the formation of these clusters (data not shown). Flow 
cytometric analysis of AT in wild-type and Rag2–/– mice demonstrated the presence of Lin–
c-Kit+Sca-1+IL-7Rα+ type 2 ILCs (Supplementary Fig. 3a). Over 80% of the Lin–
CD90+Sca-1+NK1.1– cells present in FALCs of Rag2–/– mice were ILC2 cells 
(Supplementary Fig. 3b). Immunofluorescence staining of mesenteries of Rag2–/– mice 
also identified clusters of CD90+CD11b– cells in FALCs corresponding to ILCs 
(Supplementary Fig. 3c).  
As the LTα-LTβR pathway was not required for the formation of FALCs, we 
examined the role of TNF, another key regulator of lymphoid tissue organization22, 23, 37. 
We observed half the number of FALCs as well as reduced cluster size in Tnfrsf1a–/–
Tnfrsf1b–/– mice as compared to wild-type mice (Fig. 4a,b). Conversely, in the Tnf+/ΔARE 
mice, which carry a deletion that results in the accumulation of Tnf mRNA and TNF 
protein, we observed an eight-fold increase in FALC numbers and in the size of the 
clusters as compared to wild-type littermates (Fig. 4a,b). Thus, we conclude that TNF 
signaling promoted the formation of FALCs.  
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 Colonization by the commensal flora is involved in the postnatal development and 
maturation of the gut-associated lymphoid tissues (GALT)38-41. Germ-free mice showed a 
two-fold reduction in the number of FALCs, indicating that the commensal flora partly 
contributed to their formation (Fig. 4a,b). Overall, these analyses revealed that the 
formation of FALCs is dependent on an innate lymphoid cell type different from LTi cells 
and other RORγt+ ILC3 cells and partly dependent on TNF signaling and colonization by 
the commensal flora. 
 
Peritoneal inflammation led to rapid formation of FALCs 
 
Since the formation of FALCs was increased in Tnf+/ΔARE mice, we tested the effect of 
acute sterile peritonitis on cluster formation. Peritoneal inflammation driven by zymosan 
led to a marked increase in the size and number of FALCs at day 3, with the clusters 
becoming visible without counterstaining under the dissecting microscope (Fig. 4c) and 
their numbers doubling (Fig. 4d). Immuno-fluorescence staining showed that this was 
associated with the  recruitment of CD11b+ myeloid cells (Fig. 4e) that were mostly Gr1lo/–
Ly6Clo/–F4/80+ macrophages (Supplementary Fig. 4). Thus, peritoneal inflammation leads 
to a general expansion of FALCs. 
 
TNF signals induced FALC formation 
 
To test the hypothesis that TNF contributed to FALC formation, Tnfrsf1a–/–Tnfrsf1b–/– mice 
were immunized with zymosan. Even though existing FALCs increased in size and 
recruited CD11b+ myeloid cells, zymosan failed to induce de novo formation of clusters at 
day 3 post-injection in this knockout strain. (Fig. 5a). We then asked whether TNFR-
signaling was required on stromal cells to induce formation of FALCs following zymosan 
injection. Wild-type and Tnfrsf1a–/–Tnfrsf1b–/– recipient mice were lethally irradiated, 
reconstituted with wild-type bone marrow donor cells and received an intraperitoneal 
injection of zymosan. Reconstitution of Tnfrsf1a–/–Tnfrsf1b–/– recipient mice with wild-type 
donor bone marrow did not rescue FALC formation upon inflammation at day 3 post-
injection as it did in the control wild-type recipient mice bone marrow chimeras (Fig. 5b). 
Thus, our data indicate that radiation-resistant stromal cells respond to TNF and induce 
FALC formation. 
 To determine the cellular origin of TNF, we used mouse strains with specific 
deletion of Tnf in either CD4+ T cells (T-TNF, Cd4-Cre), B cells (B-TNF, Cd19-Cre) or 
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macrophages/neutrophils (M-TNF, Lysm-Cre). Specific ablation of Tnf in T and B cells did 
not impair the induction of cluster formation upon inflammation as seen by the 3- and 2-
fold increase in cluster numbers observed in T-TNF and B-TNF mice, respectively (Fig. 
5c). In contrast, loss of Tnf expression by neutrophils and macrophages in M-TNF mice 
resulted in the absence of new FALC formation following zymosan injection, even though 
CD11b+ myeloid cells were recruited to the clusters (Fig. 5c). Intracellular flow-cytometric 
analysis confirmed that TNF+ cells were of myeloid origin (data not shown) with 40% of 
F4/80+ macrophages and Ly6ChiF4/80– monocytes displaying intra-cellular TNF 
expression in the mesenteries after zymosan injection (Fig. 5d). Once correlated to their 
cell number, macrophages represented 60% of all TNF+ myeloid cells in the mesenteries 
(Fig. 5d). Taken together, these results demonstrate the importance of macrophages as a 
key source of TNF and TNFR signaling in stromal cells for de novo formation of FALCs 
upon inflammation.  
 
FALC formation upon inflammation required iNKT cells 
 
Given the prevalence of B cells in FALCs, we evaluated their role in inducible formation of 
these clusters. To do so, we analyzed the effect of intraperitoneal injection of zymosan in 
Rag2–/– mice, lacking T and B cells, and in B cell-deficient Ighm–/– mice. B cells were not 
involved in FALC formation as shown by the three-fold increase in their number (Fig. 6a) 
and the recruitment of CD11b+ myeloid cells (Fig. 6b). However, peritoneal inflammation 
failed to induce cluster formation in Rag2–/– mice, indicating a requirement for T cells (Fig. 
6a). This result was confirmed in Tg(CD3E)26Cpt mice, in which the development of T, NK 
and NKT cells is blocked. In both Rag2–/– and Tg(CD3E)26Cpt mice, inflammation induced 
a normal recruitment of myeloid cells in FALCs (Fig. 6a,b). γδ T cells were not involved in 
FALC formation upon peritoneal inflammation as shown by a five-fold increase in the 
number of FALCs in Tcrd–/– mice following zymosan injection (Fig. 6a,b). 
 We next assessed the role of CD1d-restricted natural killer T (NKT) cells in 
inducible FALC formation. Injection of zymosan failed to induce cluster formation at day 3 
post-injection in Cd1d–/– mice (Fig. 6a,b). This result indicated an important role for NKT 
cells in FALC formation. 
 
Activation of iNKT cells induces FALCs formation 
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NKT cells recognize lipid-based antigen presented by CD1d. The best characterized NKT 
cell population is the CD1d-restricted invariant NKT cell (iNKT) population due to their 
TCRα chain usage (in mice encoded by the Tcra Vα14-Jα18 gene segments). iNKT cells 
recognize and strongly respond to the synthetic glycolipid α-galactosylceramide (α-
GalCer) presented on CD1d28. Previous studies have described the presence of iNKT cells 
in AT and their role in regulation of metabolism42-46. Flow cytometric analysis using anti-
CD3ε Abs and CD1d-PBS-57 tetramer confirmed that iNKT cells were particularly enriched 
in ATs, representing up to 6% of all lymphocytes, compared to the spleen or the mLNs that 
contained approximately 0.03% or 0.1% iNKT cells, respectively (Fig. 7a). To detect iNKT 
cells in situ, we transferred CD1d-PBS-57 tetramer-isolated CFSE-labeled iNKT cells into 
wild-type mice and showed that these cells were indeed recruited to FALCs (Fig. 7b). 
We next tested the effect of iNKT cell activation on FALC formation by 
intraperitoneal injection of α-GalCer into wild-type mice.  α-GalCer elicited a two-fold 
increase in the number of clusters as compared to control that received vehicle. This 
observation demonstrated that direct TCR activation of iNKT cells was sufficient to induce 
cluster formation (Fig. 7c). We then assessed whether TNFR pathways were also required 
for cluster formation following TCR activation of iNKT. FALC formation upon α-GalCer 
injection was abrogated in Tnfrsf1a–/–Tnfrsf1b–/– mice, indicating the need for signaling 
through these receptors (Fig. 7d).  
 To test whether iNKT cells were sufficient to rescue inflammation-induced FALC 
formation in Rag2–/– mice, we transferred sorted splenic iNKT cells or CD3hi cells by 
intraperitoneal injection in these mice, 24 h before immunization with zymosan. Only mice 
that received iNKT cells showed an increase in FALC numbers after zymosan injection 
(Fig. 7e).  
 We next tested the effect of the selective loss of iNKT cells on the formation of 
FALCs upon zymosan-induced inflammation. FALC numbers were increased two-fold in 
mice lacking the Tcra Jα18 gene segment following zymosan injection (Fig. 7f) indicating 
that iNKT cells were not absolutely required for formation of these clusters. Taken 
together, these results indicate that even though iNKT cells were sufficient to restore 
cluster formation in Rag2–/– mice, the function of iNKT cells and other non invariant CD1d 
restricted NKT cells appear to be overlapping during inflammation-induced FALC 
formation. 
 
FALC formation upon inflammation required IL-4Rα 
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Upon activation, iNKT cells produce very rapidly large amounts of TH1 or TH2 cytokines 
(IFN-γ or IL-4, respectively), that link innate and adaptive immune responses and play 
important immunoregulatory functions28. To understand the involvement of TH1 and TH2 
cytokines in inflammation-induced FALC formation, we tested the effect of zymosan-
induced inflammation in mice deficient in either of these cytokines. FALC formation 
induced by the injection of zymosan was not impaired in Ifng–/– mice, indicating that IFN-γ 
was not required (Supplementary Fig. 5). 
 In contrast, zymosan injections failed to induce formation of new clusters at day 3 
post-injection in Il4ra–/– mice, where signaling by IL-4 and IL-13 is impaired, while BALB/c 
wild-type mice responded with a two-fold increase in the number of FALCs (Fig. 8a,b). 
FALC numbers were two-times higher in the BALB/c mouse strain compared to the 
C57BL/6J strain, suggesting that the TH2 bias shown in the former contributed to their 
higher number of FALCs.  
To determine the respective contribution of IL-4 and IL-13, we studied FALC 
formation in the Il4–/– and Il13–/–mouse strains. In both mutant strains zymosan injection 
led to the formation of new clusters, suggesting that these cytokines exerted redundant 
functions in the BALB/c background (Fig. 8a,b). However, IL-13 played a critical role in 
inflammation induced FALC formation in the C57BL/6J background as shown by the 
absence of new cluster formation in Il13–/– mice at day 3 post-injection (Fig. 8c). To test 
whether IL-13 produced by iNKT cells was sufficient to rescue the inducible FALC 
formation in Il13–/–mice, we transferred sorted splenic iNKT cells into these mice, 24 h 
before immunization with zymosan. We found that IL-13-sufficient iNKT cells induced a 
slight increase in FALC numbers in Il13–/– mice but this did not reach statistical 
significance (Fig. 8c). These results indicate that iNKT production of IL-13 contributes to 
inflammation-induced FALC formation, but that additional sources of IL-13 may be 
required. We finally assessed the role of IL-4Rα signaling in the formation of FALCs driven 
by direct iNKT cell activation. α-GalCer injection failed to induce FALCs formation in Il4ra–
/– mice (Fig. 8d).  These findings indicate that formation of FALCs through direct activation 
of iNKT cells also required IL-4Rα signaling. 
 
IL-4 partially rescued FALC formation in absence of TNF 
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Our results showed that TNFR and IL-4Rα signaling were necessary for inflammation-
induced FALC formation. To test whether crosstalk between these receptors was 
necessary, we performed a serie of combinatorial and rescue experiments. Injection of 
TNF and IL-4-anti IL-4 complex (IL-4c) alone or in combination was not sufficient to induce 
cluster formation (Supplementary Fig. 6a), indicating that other factors were involved in 
this process. Intraperitoneal injection of TNF could not rescued zymosan-induced FALC 
formation in Il4ra–/– mice. In contrast, intraperitoneal injection of IL-4c in Tnfrsf1a–/–
Tnfrsf1b–/– mice induced a small but significant increase in the number of zymosan-
induced FALCs, indicating that IL-4 could partially rescue cluster formation in the absence 
of TNFR signaling and thus may act downstream of TNF (Supplementary Fig. 6b). 
 
DISCUSSION 
 
In this report we defined the requirements for the formation of a new type of 
lymphoid tissue called Fat Associated Lymphoid Clusters. In the peritoneal cavity, 
mesenteric FALCs and omental milky spots accounted for the quasi-totality of the 
lymphoid clusters associated with AT. In the pleural cavity, the pericardium and 
mediastinum showed a density of lymphoid clusters approaching the levels of the 
omentum. FALCs contained a high proportion of B1 cells with no apparent B and T cell 
segregation, comparable to what has been reported previously for the milky spots of the 
omentum12. FALCs expressed high levels of CXCL13 required for efficient recruitment of B 
cells, which upon immune challenge with T-dependent or -independent antigens actively 
proliferate, and undergo differentiation towards plasma cells or GC cells in these clusters. 
The function of FALCs and milky spots are probably overlapping in the peritoneal cavity, 
but FALCs contained in the mediastinal and the pericardial fat are likely to be the main 
sites for the organization of immune responses and for retention of B1 cells by CXCL13 in 
the pleural cavity. 
FALC development in mice was constitutive and its initiation coincided with 
weaning. Establishment of a normal number of FALCs in adult mice was dependent on 
TNFR signaling and colonisation by commensal flora suggesting a role for Pattern 
Recognition Receptors. FALCs were totally absent in Rag2–/–Il2rg–/– mice and 
immunofluorescence and flow-cytometric analysis in Rag2–/– mice indicated that cells 
present in the clusters in absence of T and B cells were ILCs. Importantly, FALC formation 
was independent of the presence of LTi cells and other ILC3 cells as well of LTαβ-LTβR-
signaling which resembles the formation of nasal associated lymphoid tissues (NALT)47.  
13 
 
 
 
Peritoneal inflammation induced a rapid neo-formation of a large number of FALCs 
reaching a two- to three-fold increase compared to resting conditions. This effect was 
dependent on TNF expression by myeloid cells and TNFR signaling on stromal cells. 
Coupling of inflammation and rapid FALC formation provide a platform to link innate and 
adaptive immune responses that support rapid B cell proliferation and natural antibody 
secretion in the body cavities following infection. Neo-formation of FALCs also 
necessitated the activation of iNKT cells and signaling through the IL4Rα. Interestingly, 
triggering of iNKT cells through TCR ligation was sufficient to induce formation of FALC 
that was also dependent on TNFR and IL-4Rα signaling. Therefore, induction of FALC 
formation seemed to require both an inflammatory signal, delivered by TNF, and a 
Th2/Resolution signal transduced by IL-4Rα. How FALC formation is timed with the 
iniation of the resolution of inflammation and whether FALCs play a role in the resolution 
phase remains to be investigated. 
We and others have recently shown that ATs constitute an important reservoir of 
stem cells for the formation of lymphoid stroma in LNs during development22, 48 and 
immune responses49. It is thus conceivable that FALC stromal cells originate from AT stem 
cells or peri-vascular cells, as has been recently shown for FDCs22.  
This work constitutes the first report of NKT cells having a lymphoid organogenic 
activity. Not only were NKT cells necessary for the formation of FALCs during 
inflammation, but also their sole activation was sufficient to induce neo-formation of 
clusters. A number of studies have recently highlighted the role of NKT cells in the 
regulation of AT metabolism in normal nutrient homeostasis and during obesity42-46. 
Whether the metabolic activity of NKT cells is linked to their capacity to induce FALC 
formation and alter the homeostasis of other hematopoietic cells present in ATs remains to 
be investigated.  
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FIGURE LEGENDS 
 
Figure 1. Distribution of FALCs in VAT. 
(a) Whole mount immunofluorescence staining of the mesenteries allowing visualisation of 
CD45+ FALCs (green). (b) Density of hematopoietic clusters (number of clusters/g adipose 
tissue) in the main fat deposits of the peritoneal (omental (n=8 mice), gonadal (n=7) and 
mesenteric (n=6) adipose tissues) and pleural cavities (mediastinal (n=13) and pericardial 
(n=8) adipose tissues) and in the subcutaneous fat (n=7). Data points and mean shown. 
Data pooled from two independent expts. (c) Whole mount immunofluorescence staining 
showing a mesenteric FALC with CD11b+ myeloid cells (blue), CD45+ hematopoietic cells 
(green), IgM+ B cells (red), and CD4+ T cells (white). Picture representative of clusters 
from multiple independent experiments. (d) Whole mount immunofluorescence staining 
showing a mesenteric FALC with CD45+ hematopoietic cells (green), CD31+ blood 
endothelial cells (red) and Lyve-1+ cells (blue). Scale bar 50 µm. Picture representative of 
8 clusters from 4 mice in two independent experiments (e) Enumeration of the mesenteric 
clusters of newborns and animals aged between 1 and 32 weeks (n=5, 5, 5, 5, 7, 18, 7, 7 
mice per group). Data representative of three independent experiments. Data points and 
mean shown.  
 
Figure 2. CXCL13 expression by FALC stromal cells is necessary for B cell 
recruitment. 
(a) Real-time PCR analysis of the indicated mRNA in LNs, mesenteric FALCs and 
adjacent fat (n=5, 4, 5). Mann-Whitney nonparametric two-tailed test between FALCs and 
fat Cxcl13 p=0.0159, Tnf p=0.0286, Ccl21 p=0.1143, Ltb p=0.0079, Ccl19 p=0.2857, Il7 
p=0.0286. (b-c) Numbers of mesenteric clusters in WT, Plt/plt, Ccr7–/–, and Cxcr5–/– mice 
(n=7, 6, 6, 6 mice per group), (b) and whole mount immunofluorescence staining showing 
FALCs with CD11b+ myeloid cells (blue), CD45+ hematopoietic cells (green), IgM+ B cells 
(red), and CD4+ T cells (white) (c) in the indicated mouse strains. Picture representative of 
8 clusters from 4 mice from at least 2 independent experiments. (d) Whole mount 
immunofluorescence staining showing mesenteric FALCs in the indicated mouse strains 
with CD45+ hematopoietic cells (green), and CXCL13+ stromal cells (red). Picture 
representative of 8 clusters from 4 mice from 2 independent experiments. Scale bar 50 
µm. *p < 0.05, **p < 0.01 and NS not significant.  
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Figure 3. B cell activation and differentiation in FALCs upon peritoneal immune 
challenge.  
(a) Quantification of NP-specific IgM and IgG antibody forming cells (AFC) using ELISpot 
assays with cells from isolated FALCs and spleens after NP-Ficoll IP immunization of 
QMxB6 mice. Data correspond to PBS and NP-Ficoll treated mice (n=12,12) pooled from 2 
independent experiments using 2.5 x 105 cells per well (n=9 FALCs and 12 spleen). Each 
symbol represents an individual mouse. Mann-Whitney nonparametric two-tailed test 
between PBS and NP-Ficoll immunised mice, FALCs IgM p=0.0037, spleen IgM p<0.0001, 
FALCs IgG p=0.0275 and spleen IgG p<0.0001. (b) Whole mount immunofluorescence 
staining of the mesenteries of Cγ1-CrexQMmTmG mice that were immunized with either 
PBS (all cells red) or NP-Ficoll that results in the generation of IgG1+-switched B cells 
(green) in FALC. Cγ1-CrexQMmTmG carry one copy of the Cre recombinase in the 
constant region of the Cγ1 Igh gene, one copy of the NP-specific Igh from QM mice and 
the membrane Tomato membrane Green (mTmG) reporter. NP immunization induced B 
cell activation and Ig class switching with the concomitant expression of Cre recombinase 
that resulted in the membrane reporter switch from IgM (red) to IgG (green). Arrows 
indicate the presence of B cells that have undergone switching (green). (c-d) Peritoneal 
lavage cells from QM/QM EYFP+/– mice were transferred by intravenous (IV) injection into 
C57BL/6J mice 24 hours before immunization with Alum-precipitated NP-OVA. (c) Flow 
cytometric analysis of cells isolated from the mesenteries, spleen and mLN of PBS and 
NP-OVA-immunized mice showing the percentage of EYFP+CD19+ NP-specific B cells in 
live CD45+ gate (top) and percentage of CD38–GL7+ GC B cells in EYFP+CD19+ NP-
specific B cells gate (bottom). (d) Quantification of the cell number of NP-specific B cells 
(left) and NP-specific GC B cells (right). Data correspond to PBS and NP-OVA treated 
mice (n=5, 6) pooled from 2 independent experiments. Each symbol represents an 
individual mouse. Mann-Whitney nonparametric two-tailed test between PBS and NP-OVA 
treated mice, number of NP+ B cells/1.106 cells in the mesenteries p= 0.0079, spleen 
p=0.0317, mLN p=0.0079, and number of NP+ GC B cells/1.106 cells in the mesenteries 
p=0.0043, spleen p=0.0043, mLN p=0.0043. (e-f) C57BL/6J mice were immunized IP with 
Alum precipitated-PE. (e) Flow-cytometric analysis of the mesenteries of naïve and PE 
immunised mice showing percentages of PE+CD19+ B cells in live CD45+ gate (upper 
row), and CD38-GL7+ GC B cells in PE+CD19+ gate (lower row). (h) Quantification of the 
cell number of PE+ GC B cells. Data correspond to PBS and PE/Alum immunised mice 
(n=6, 7) pooled from 2 independent experiments. Mann-Whitney nonparametric two-tailed 
test between PBS and PE/Alum immunised mice, number of PE+ GC B cells/1.106 cells in 
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the mesenteries p= 0.0043, spleen p=0.0012, mLN p=0.0012 (h). *p < 0.05, **p < 
0.01, ***p< 0.001 and ****p <0.0001.  
 
Figure 4: Factors controlling the development of FALCs 
(a) Number of mesenteric clusters in the indicated knockout mouse strains. Data 
correspond to WT, Ltbr–/–,  Lta–/–, Rorc–/–, Rag2–/–, Rag2–/–IL2rg–/–, germ free (GF), 
Tnfrsf1a–/–Tnfrsf1b–/– and Tnf+/ ΔARE mice pooled from at least 2 independent experiments 
(n=19, 13, 8, 7, 10, 7, 9, 9, 9 mice per group). Mann-Whitney nonparametric two-tailed test 
between WT and Rag2–/–IL2rg–/– p< 0.0001, WT and GF p<0.0001, WT and Tnfrsf1a–/–
Tnfrsf1b–/– p=0.0002, WT and Tnf+/ ΔARE p<0.0001  (b) Whole mount immunofluorescence 
staining showing FALCs with CD11b+ myeloid cells (blue), CD45+ hematopoietic cells 
(green), IgM+ B cells (red), and CD4+ T cells (white) in the indicated mouse strains. Picture 
representative of 8 clusters from 4 mice from at least 2 independent experiments. (c-e) 
Microphotographs of the mesenteries of WT mice (c), number of clusters (d) and whole 
mount immunofluorescence staining as in b (e) after PBS or zymosan injection (n=8, 9).  
Data pooled from 2 independent experiments. Picture representative of 8 clusters from 4 
mice from 2 independent experiments. Mann-Whitney nonparametric two-tailed test 
p<0.0001. Scale bar 50 μm. *p<0.001 and ** p <0.0001. 
 
Figure 5: TNF is required for FALC formation upon inflammation 
(a) Number of clusters found in the mesenteries of Tnfrsf1a–/–Tnfrsf1b–/– mice and whole 
mount immunofluorescence staining showing FALCs with CD11b+ myeloid cells (blue), 
CD45+ hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells (white) 72 hours 
after PBS or zymosan injection. Data pooled from 2 independent experiments (n=6, 6). 
Mann-Whitney nonparametric two-tailed test p=0.2424. Picture representative of 8 clusters 
from 4 mice from 2 independent experiments. (b) Number of clusters present in the 
mesenteries of WT and Tnfrsf1a–/–Tnfrsf1b–/– mice reconstituted with WT bone marrow and 
whole mount immunofluorescence staining as in a after PBS or zymosan injection. Data 
correspond to WT BM into WT mice (n=5, 5) and WT BM into Tnfrsf1a–/–Tnfrsf1b–/–mice 
(n=6, 6) per group pooled from 2 independent experiments. Mann-Whitney nonparametric 
two-tailed test, WT BM into WT mice p=0.0079, and WT BM into Tnfrsf1a–/–Tnfrsf1b–/– 
mice p=0.1688. Picture representative of 8 clusters from 4 mice from 2 independent 
experiments. (c) Enumeration of clusters in the mesenteries of the indicated mutant 
mouse strains and whole mount immunofluorescence as in a after PBS or zymosan 
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injection. Data correspond to WT mice (n=7, 7), T-Tnf–/– (n=6, 8), B-Tnf–/– (n=4, 6) and M-
Tnf–/– (n=8, 13) mice in the control and treated group pooled from 2 independent 
experiments. Mann-Whitney nonparametric two-tailed test WT p=0.0006, T-Tnf–/– 
p=0.0007, B-Tnf–/– p=0.0048 and M-Tnf–/– p=0.2156. Picture representative of 8 clusters 
from 4 mice from 2 independent experiment. Scale bar 50 μm. Each symbol represents an 
individual mouse. (d) Flow-cytometric analysis showing TNF intra-cellular staining 2 hours 
post zymosan injection in mesenteric eosinophils (gated as CD45+CD11b+SSChighSiglec-
F+), neutrophils (gated as CD45+CD11b+Siglec-F-Ly6-Ghigh), macrophages (gated as 
CD45+CD11b+Siglec-F-F4/80+) and monocytes (gated as CD45+CD11b+Siglec-F-F4/80-
Ly6-chigh). Quantification of the percentages of TNF+ cells after zymosan in myeloid 
subsets is shown in bar chart. Data correspond to WT mice in the control and treated 
group (n=8, 8) pooled from 2 independent experiments. Mann-Whitney nonparametric two-
tailed test, eosinophils p=0.1593, neutrophils p=0.3935, macrophages p=0.0002 and 
monocytes p=0.0002. *p < 0.01, **p< 0.001 
 
Figure 6: CD1d restricted NKT cells are required for FALC formation 
(a-b) Number of mesenteric clusters in the indicated mouse strains (a) and whole mount 
immunofluorescence staining showing FALCs with CD11b+ myeloid cells (blue), CD45+ 
hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells (white) 72 hours after 
PBS or Zymosan injection (b). Data correspond to Rag2–/– (n=6, 6), Ighm–/– (n=5, 5), 
Tg(CD3E)26Cpt (n=5, 5), Tcrd–/– (n=4, 6) and Cd1d–/– (n=5, 6) mice in the control and 
treated group pooled from 2 independent experiments. Mann-Whitney nonparametric two-
tailed test, Rag2–/– p=0.5693, Ighm–/– p=0.0025, Tg(CD3E)26Cpt p=0.7857, Tcrd–/– 
p=0.0095 and Cd1d–/– p=0.5065. Picture representative of 8 clusters from 4 mice from 2 
independent experiments. Scale bar 50 μm. *p <0.01, NS not significant. 
 
Figure 7: iNKT cell activation induces FALC formation 
(a) Flow cytometry of the mesenteries, spleen and mLN showing the percentage of CD3ε+ 
CD1d-α-GalCer tetramer+ iNKT cells in the lymphocyte gate. Data are representative of 3 
independent experiments (b) Whole mount immunofluorescence staining showing CFSE 
loaded iNKT cells (green) in mesenteric FALCs with CD11b+ myeloid cells (blue) and IgM+ 
B cells (red) 24 hours after transfer. Data representative of 8 clusters from 4 mice in 2 
independent experiments. (c-d) Numbers of mesenteric clusters and whole mount 
immunofluorescence staining showing FALCs with CD11b+ myeloid cells (blue), CD45+ 
hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells (white) 72 hours after 
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vehicle or α-GalCer injection. Data correspond to WT mice in the control and treated group 
(n=6, 9) pooled from 2 independent experiments (c) and Tnfrsf1a–/–Tnfrsf1b–/– mice in the 
control and treated group (n=9, 7) pooled from 3 independent experiments. Picture 
representative of 8 clusters from 4 mice from at least 2 independent experiments (d). 
Mann-Whitney nonparametric two-tailed test, WT p=0.0004 and Tnfrsf1a–/–Tnfrsf1b–/– 
p=0.2831. (e) Numbers of mesenteric clusters and whole mount immunofluorescence 
staining showing FALCs with CD11b+ myeloid cells (blue) and CD45+ hematopoietic cells 
(green) 72 hours after PBS or zymosan injection in Rag2–/– mice (n=4, 5) and Rag2–/– mice 
transferred with high purity sorted CD3high T cells or CD3ε+ CD1d-α-GalCer tetramer+ iNKT 
cells (n=6, 5). Data pooled from 4 independent experiments. Mann-Whitney nonparametric 
two-tailed test p=0.0043. Picture representative of 8 clusters from 4 mice from 4 
independent experiments.  (f) Numbers of mesenteric clusters in Tcra-Jα18–/– mice and 
whole mount immunofluorescence as in c 72 hours after PBS or zymosan injection (n=7, 
6). Data correspond pooled from 2 independent experiments. Mann-Whitney 
nonparametric two-tailed test p=0.0012. Picture representative of 8 clusters from 4 mice 
from 2 independent experiments. Scale bar 50 μm. *p < 0.01, **p< 0.001 and NS not 
significant. 
 
Figure 8: Formation of FALCs is dependant on IL-4Rα signaling 
(a-b) Numbers of mesenteric clusters in the indicated mouse strains (a) and whole mount 
immunofluorescence staining showing FALCs with CD11b+ myeloid cells (blue), CD45+ 
hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells (white) 72 hours after 
PBS or Zymosan injection. Data correspond to WT (n=7, 6), Il4ra–/– (n=5, 5), Il4–/– (n=5, 6), 
and Il13–/– mice (n=4, 6) in the control and treated group pooled from 2 independent 
experiments. Mann-Whitney nonparametric two-tailed test, WT p=0.0012, Il4ra–/– 
p=0.8016, Il4–/– p=0.0043, and Il13–/– mice p=0.0095. Picture representative of 8 clusters 
from 4 mice from 2 independent experiments.  Scale bar 50 μm. (c) Numbers of 
mesenteric clusters in Il13–/– mice and Il13–/– mice transferred with high purity sorted 
CD1d-α-GalCer tetramer+ iNKT cells or CD3high T cells 72 hours after PBS or zymosan 
injection. Data correspond to Il13–/– control injected with PBS (n=7), injected with zymosan 
(n=6), received CD3high T cells and was injected with zymosan (n=6) and received iNKT 
cells and was injected with zymosan (n=6) pooled from 2 independent experiments. Mann-
Whitney nonparametric two-tailed test p=0.3625. (d) Numbers of mesenteric clusters in 
C57Bl/6J and Il4ra–/– mice 72 hours after PBS or zymosan injection. Data correspond to 
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WT control (n=9) and treated (n=5) and Il4ra–/– control (n=7) and treated (n=5) pooled from 
2 independent experiments. Mann-Whitney nonparametric two-tailed test, WT p=0.001 
and Il4ra–/– p=0.2159. *p < 0.01, **p< 0.001 and NS not significant. 
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METHODS 
 
Mice 
C57BL/6J (H-2b), Ltbr–/–, Lta–/–, Rorc–/–, Rag2–/–, Rag2–/–γc–/–, Tnfrsf1a–/– Tnfrsf1b–/–, 
Tnf+/ ΔARE50, and Eyfp-Rosa26, Plt/plt, Ccr7–/–, Cxcr5–/–, QM/QM (Igh-Jtm1(VDJ-17.2.25)Wabl)36 
(IghNP/NP Igk–/–), QM × B6 (IghNP/+ Igk+/–), QM/QM EYFP+ (QM-EYFP+), Cγ1-
CrexQMmTmG (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo)(IghNP/Cγ1Cre Igk–/–)51,52, 
Tg(CD3E)26Cpt, Cd1d–/–, Tnffl/flLysm-Cre (M-TNF)53, Tnffl/flCd4-Cre (T-TNF)53 or 
Tnffl/flCd19-Cre (B-TNF)53, Tcra-Jα18–/–, Vα14-Jα18 Tg, Ifng–/–, Il13–/– (on C57BL/6J 
background), Il4–/–, Il4ra–/–, Il13–/– (on BALB/c background) and BALB/c (H-2d) mice were 
bred and maintained under specific pathogen-free conditions. Il13–/–, and Il4ra–/– mice 
were used in C57BL/6J or BALB/c background for experiments as indicated. Germ-free 
C57BL/6J mice were obtained from the Institut Pasteur, Paris, France. Bone marrow 
chimeras were generated after irradiation of C57BL/6J and Tnfrsf1a–/–Tnfrsf1b–/–, mice and 
reconstitution with bone marrow from C57BL/6J. All experiments in this report were 
performed according to UK Home Office and local ethics committee regulations. 
 
Immunization and peritoneal cavity inflammation 
QM/QM (IghNP/NP Igk–/–), QM × B6 (IghNP/+ Igk+/–), and Cγ1-CrexQMmTmG mice were 
immunized by intraperitoneal injection of 30 µg NP40-Ficoll per mouse (Biosearch 
Technologies). B cell activation from mesenteries, spleen, mLN and peritoneal cavity 
lavage was assessed 24 h later (QM/QM mice) or 4 d later (QM × B6 and Cγ1-
CrexQMmTmG mice) by flow cytometry and ELISPOT. IgG1 switching in the mesenteries 
was visualized at day 4 by whole-mount stereo-microscopy. For cell transfer experiments, 
2 × 106 peritoneal lavage cells from QM-EYFP+ mice were transferred IP into recipient 
C57BL/6J mice, before immunization with NP-OVA (50 µg) precipitated with Alum on the 
next day. B cell activation was assessed at day 8 in the mesenteries, spleen and mLN. For 
the PE immunization experiment, C57BL/6J mice were immunized IP with Phycoerythrin 
(PE) (50 µg) and B cell activation was analyzed at day 8-9 in the mesenteries, spleen and 
mLN. Peritoneal cavity inflammation was induced by Intraperitoneal injection of 1 mg 
Zymosan (Sigma). 72 h later, B cell activation was assessed by flow cytometry, FALC 
number and composition were assessed by whole mount fluorescence staining and 
confocal analysis. Treatment of mice with IL-4c was performed as previously described54. 
IL-4c consisted of a 2:1 molar ratio of recombinant mouse IL-4 (Peprotech) and anti-IL-4 
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mAb (clone 11B11;BioXcell). Mice were injected i.p. with IL-4c containing 5 µg of IL-4 and 
25 µg of 11B11, or PBS vehicle control on days 0 and 2. For co-administration 
experiments with Zymosan, mice were given 1 mg Zymosan on day 0 with IL-4c on day 0 
and day 2. Mice were treated with 1 µg TNF (Peprotech) or PBS control on day 0 and day 
2. For co-administration experiment with IL-4c, mice were treated with IL-4c and TNF on 
day 0 and day 4. For co-administration experiment with Zymosan, mice were given 1 mg 
Zymosan on day 0 and TNF on day 0 and day 2. In all experiments with IL-4c and TNF, 
analysis of the mesenteries was performed on day 4. 
 
Cell isolation and cell sorting  
For flow cytometric analysis of the mesenteries, tissues were digested for 30 min in RPMI 
containing 1% fetal calf serum and 1 mg/ml Collagenase D (Roche) at 37 °C on constant 
agitation (110 r.p.m.). Tissue suspensions were filtered was filtered through 40 µm cell 
strainers before staining. Peritoneal cavity lavage was performed by injection of 5 ml cold 
PBS in the peritoneal cavity. Isolation of splenic CD3εlow CD1d-PBS-57 Tetramer+ iNKT 
cells and CD3εhi T cells was performed via MoFlow (Dako Cytomation) cell sorting. 5 × 105 
cells (purity> 98%) were injected in the peritoneal cavity of Rag2–/–, 12 h before induction 
of peritoneal cavity inflammation. Mesenteries were analyzed for cluster formation 72 h 
later. For CFSE labeling, iNKT cells were isolated by high speed cell sorting from the 
spleen of Vα14 transgenic mice in which 30–40% of all cells are positive for α-GalCer-
loaded CD1d tetramers and were incubated for 10 min at 22°C with 5 µM CFSE 
(eBiosciences) according to manufacturer indications prior to intraperitoneal injection. 
CD1d-PBS57 loaded tetramers were kindly provided by the National Institutes of Health 
Tetramer Facility (Atlanta GA, USA). 
 
Antibodies and reagents for flow cytometry 
Antibodies and reagents used for flow cytometry are listed in Supplementary Table 1. 
Single-cell suspensions were stained with primary conjugated antibodies followed by 
secondary antibodies. NP-specific B cells were detected with NP-PE, added with the 
primary antibody staining mix. iNKT cells were detected with CD1d tetramer conjugated 
with APC preloaded with PBS-57 (an analog of α-GalCer). CD1d-PBS-57-APC was also 
added to the primary antibody staining mix. For Ki67 nuclear staining, cells were fixed and 
permeabilized with the Foxp3 Fixation/Permeabilization kit (eBiosciences). Flow cytometric 
analysis was performed using Cyan (BD Biosciences) with forward/side scatter gates set 
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to exclude non-viable cells. Data were analyzed with FlowJo software (version 8.8.3, Tree 
Star). 
 
FALC isolation  
Clusters were isolated using a fluorescent stereomicroscope from unfixed mesenteries of 
EYFP+ mice in which the bright EYFP+ lymphoid aggregates could be visualized without 
prior fluorescent staining. Isolated clusters were used for qPCR analysis. 
 
ELISPOT assays. 
2.5 × 105 cells from the mesenteries or spleen were seeded into precoated NP15-BSA (5 
µg/ml)- nitrocellulose microtiter plates. After 24 h culture the plates were washed and 
incubated in isotype specific alkaline phosphatase-conjugated antibody IgM-AP1/ IgG-AP1 
(SouthernBiotech) diluted in PBS-1%BSA for 2 h at 22°C and developed using Fast 
BCIP/NBT alkaline phosphatase substrate (Sigma). Spots were counted using an AID 
ELISpot reader (Autoimmun Diagnostika GmbH) with Eli4 software (Autoimmun 
Diagnostika GmbH). 
 
RT-PCR and real-time RT-PCR 
mRNAs were isolated from tissues using the RNeasy mini kit (Qiagen), and reverse 
transcription was performed using the High capacity reverse transcription cDNA synthesis 
kit (Applied Biosystems). Quantitative RT-PCR was performed using primers and probes 
from Applied Biosystems for Cxcl13 (Mm00444533_m1), Ccl21 (Mm03646971_gH), Ccl19 
(Mm00839967_g1), Tnf (Mm00443258_m1), Ltb (Mm00434774_g1) and Il7 
(Mm01295803_m1) using ABI PRISM 7900HT instrument. The means of duplicate of the 
ratio of the gene of interest to Actb are shown.  
 
Immunofluorescence staining 
After dissection, whole mesenteries were fixed in PBS 4%PFA for 1 h at 4 °C, 
permeabilized in PBS 1%Triton for 30 min at 22°C. Tissues were then stained with primary 
antibodies for 1 h at 22°C on constant slow agitation. After wash, tissues were stained with 
secondary antibodies for 30 min at 22°C. Antibodies used are listed in Supplementary 
Table 1. Tissues were mounted using Vectashield mounting medium (Vector 
Laboratories). 
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Image acquisition and analysis of confocal images 
Confocal images were acquired using a Zeiss LSM 510 laser scanning confocal head with 
a Zeiss Axio Imager Z1 microscope. For all analysis of clusters a minimum of 12 clusters 
were analysed from 4 mice of each group and pooled from 2 independent experiments. 
 
Statistical analysis 
Statistical significance was determined for all analysis with a Mann-Whitney non 
parametric two-tailed test.  
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 Supplementary Figure 1 
 FALC morphology 
Whole mount immunofluorescence staining showing a representative array of FALCs harvested from the mesenteries of a single 
C57BL/6J (WT) mouse with CD11b+ myeloid cells (blue), CD45+ hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells 
(white) on the top row and without CD45 staining on the bottom row. Pictures are representative of 6 mice. Scale bar 50 µm. 
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 Supplementary Figure 2 
 B cell activation in FALCs upon peritoneal immune challenge  
 
(a) Flow cytometry of the mesenteries of QM/QM (IgHNP/NP Igκ–/–) mice 24 hours post PBS (left panel) and NP-Ficoll (right panel) IP 
injection. In the CD45+ hematopoietic fraction, the different B cell subsets were identified according to the expression of CD19 and 
CD11b (first row), CD19 and CD5 (second row). The percentages of NP+Ki67+ cells in the B2 (CD19+CD11b−CD5-), B1c 
(CD19+CD11b−CD5+), B1a (CD19+CD11b+CD5+) and B1b (CD19+CD11b+CD5-) cell subsets are shown (third and forth row). Image 
representative of 2 independent experiments (n=6, 5). (b) Quantification of the percentage of NP+Ki67+ activated B cells in the 
mesenteries, peritoneal cavity lavage (PCL) and spleen of QM/QM mice 24 hours after PBS or NP-Ficoll injections. Data are 
representative of 2 independent experiments (n=6, 5). Each symbol represents an individual mouse. Mann-Whitney nonparametric two-
tailed test, B2 p=0.1905 and p=0.0079, B1c p=0.0159, p=0.0079, B1a p=0.0159, p=0.0079, B1b p=0.0159, p=0.0079. (c) Whole mount 
immunofluorescence staining showing FALCs from QM/QM mice after PBS or NP-Ficoll injection with CD11b+ myeloid cells (blue), 
CD45+ hematopoietic cells (green) and IgM+ B cells (red). Pictures representative of 8 clusters from 4 mice for each condition. Scale 
bar 50 μm. *p < 0.05, **p < 0.01, ***p< 0.001, ****p < 0.0001, and NS not significant. 
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 Supplementary Figure 3 
 ILC2 in VAT and FALCs  
 
(a) Flow cytometry of the mesenteries showing CD45+Lin-c-Kit+Sca-1+IL-7Rα+ ILC2 in WT (first row) and Rag2–/– (second row) mice 
(NK1.1 and CD4 present in Lin cocktail). Data representative of 4 mice (b) Flow cytometric analysis of the mesenteries showing 
CD45+Lin-Sca-1+NK1.1- ILC2 and CD45+Lin-Sca-1-+NK1.1+ NK cells in Rag2–/– mice.  Data representative of 4 mice (c) Whole mount 
immunofluorescence staining showing FALCs in Rag2–/– with CD11b+ myeloid cells (blue) and CD90+ ILC (green). The picture is 
representative of 8 clusters from 4 mice. Scale bar 50 μm.  
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 Supplementary Figure 4 
 Myeloid cells are recruited to FALCs upon inflammation  
Whole mount immunofluorescence staining showing FALCs containing CD11b+ myeloid cells (blue) and Ly6C+ monocytes (first row, 
green), Gr1+ granulocytes (second row, green) or F4/80+ macrophages (third row, green) after zymosan injection. Pictures are 
representative of 8 clusters from 4 mice. Scale bar 50 µm. 
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 Supplementary Figure 5 
 IFN-γ  is not necessary for FALC formation upon inflammation 
 
Number of clusters found in the mesenteries of Ifng–/– mice and whole mount immunofluorescence staining showing FALCs with 
CD11b+ myeloid cells (blue), CD45+ hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells (white) 72 hours after IP injection 
of PBS or zymosan. Data corrrespond to control (n=6) and treated (n=4) mice pooled from 2 independent experiments. Each symbol 
represents an individual mouse Mann-Whitney nonparametric two-tailed test, p=0.0095.  Pictures are representative of 8 clusters from 
4 mice. Scale bar 50 µm. Scale bar 50 μm. **p < 0.01. 
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 Supplementary Figure 6 
 Partial rescue of inflamation-induced FALC formation with IL-4c in the absence of TNF signaling 
 
(a) Number of clusters found in the mesenteries of C57BL/6J (WT) mice and whole mount immunofluorescence staining showing 
FALCs with CD11b+ myeloid cells (blue), CD45+ hematopoietic cells (green), IgM+ B cells (red), and CD4+ T cells (white) four days after 
PBS, TNF, IL-4c and both TNF and IL4c injections. Data correspond to control (n=6) and TNF (n=6), IL-4c (n=7) and TNF+IL-4c (n=7) 
treated mice, pooled from 2 independent experiments. Mann-Whitney nonparametric two-tailed test, PBS and TNF p=0.4248, PBS and 
IL-4c p=0.4156, PBS and TNF+IL-4c p= 0.7964. Pictures are representative of 8 clusters from 4 mice for each condition. (b) Number of 
clusters found in the mesenteries of C57BL/6J (WT), Il4ra–/– and Tnfrsf1a–/– Tnfrsf1b–/– mice and whole mount immunofluorescence 
staining as in a, 4 days after PBS, zymosan, zymosan+TNF, and zymosan+IL-4c injections. Data correspond to PBS (n=13), zymosan 
(n=15) and zymosan+TNF (n=9) treated WT mice pooled from 3 independent experiments, and to PBS (n=7), zymosan (n=7) and 
zymosan+TNF (n=8) treated Il4ra–/– mice pooled from 2 independent experiments, and to zymosan (n=7) and zymosan+IL-4c (n=7) 
treated Tnfrsf1a–/– Tnfrsf1b–/– mice pooled from 2 independent experiments. Each symbol represents an individual mouse. Mann-
Whitney nonparametric two-tailed test WT PBS and zymosan p<0.0001, WT PBS and zymosan+TNF p=0.0052, Il4ra–/– PBS and 
zymosan p=0.0105, Il4ra–/– PBS and zymosan+TNF p=0.0365, Il4ra–/– zymosan and zymosan+TNF p=0.7574, and Tnfrsf1a–/– Tnfrsf1b–
/– zymosan and zymosan+IL-4c p=0.0029. Pictures are representative of 8 clusters from 4 mice for each condition. Scale bar 50 μm. 
*p < 0.05, **p < 0.01, ***p< 0.001 and ****p <0.0001, NS not significant. 
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Supp. Table 1. Antibody List 
 
Reagent 
 
Clone 
 
Conjugate 
 
Source 
 
CD1d-PBS57 tetramer 
 
 
APC 
 
NIH Tetramer Facility, 
Atlanta, GA, USA 
Donkey anti-Goat 
 
AlexaFluor555  Invitrogen 
Donkey anti-IgM Polyclonal Rhodamine Red  Jackson Laboratories 
Goat anti-Cxcl13 Polyclonal Unconjugated R&D Systems 
Mouse anti-Ki67 B56 Alexa647 BD Pharmingen 
Mouse anti-NK1.1 PK136 PE eBiosciences 
NP 
 
PE Biosearch Technologies 
Rat anti-CD11b M1/70 eFluor450  eBiosciences 
  PerCP-Cyanine5.5 eBiosciences 
Rat anti-CD138  281-2  PE eBiosciences 
Rat anti-CD19 eBio1D3 PECy7  eBiosciences 
Rat anti-CD31 390 Biotin eBiosciences 
Rat anti-CD38 90 PerCP-eFluor 710 eBiosciences 
Rat anti-CD4 GK1.5 eFluor660 eBiosciences 
Rat anti-CD45 RA3-6B2 eFluor450 eBiosciences 
 
30-F11  PerCP BD Pharmingen 
Rat anti-CD45.2 104 FITC eBiosciences 
 104 Brilliant Violet 650 Biolegend 
Rat anti-CD5 53-7.3 Biotin eBiosciences 
Rat anti-CD90.2 30-H12 FITC eBiosciences 
Rat anti-CD117 (c-Kit) ACK2 APC eBiosciences 
Rat anti-CD127 (IL-7Ra) A7R34 PE-Cyanine7 eBiosciences 
Rat anti-F4/80 BM8 FITC eBiosciences 
  PE-Cyanine7  
Rat anti-GL7 GL-7 eFluor450  
Rat anti-Ly-6C HK1.4 Alexa Fluor488 eBiosciences 
  Alexa Fluor647  
Rat anti-Ly-6G (Gr-1) RB6-8C5 FITC eBiosciences 
Rat anti-Ly6G 1A8 APC/Cy7 Biolegend 
Rat anti-Lyve-1 ALY7 eFluor660 eBiosciences 
Rat anti-Sca-1 D7 FITC eBiosciences 
Rat anti-Siglec-F ES22-10D8 PE Miltenyi 
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Streptavidin  AlexaFluor555 Invitrogen 
Streptavidin  APC.Cy7 eBiosciences 
Streptavidin 
 
Pacific Orange  Invitrogen 
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Reagent 
 
Clone 
 
Conjugate 
 
Source 
 
Lineage 1 
   Armenian Hamster anti-CD3e 145-2C11 PE eBiosciences 
Armenian Hamster anti-CD11c N418 PE eBiosciences 
Rat anti-CD19 eBio1D3 PE eBiosciences 
Rat anti-Ly-6G (Gr-1) RB6-8C5 PE eBiosciences 
Rat anti-NK1.1 PK136 PE eBiosciences 
Rat anti-TER-119 TER-119 PE eBiosciences  
 
Lineage 2 
   Armenian Hamster anti-TCRb H57-597 Biotin eBiosciences 
Armenian Hamster anti-TCRgd UC7-13D5 Biotin eBiosciences 
Rat anti-B220  RA3-6B2 Biotin eBiosciences 
Rat anti-CD5 53-7.3 Biotin eBiosciences 
Rat anti-CD8a 53-6.7 Biotin eBiosciences 
Rat anti-CD11b M1/70 Biotin eBiosciences 
 
 
Mouse IgG-AP  Southern Biotech 
Goat anti-mouse IgM-AP Southern Biotech 
 
PE    Prozyme 
 
 
 
